Live Breaking News & Updates on Biosion Inc

Stay updated with breaking news from Biosion inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biosion Announces FDA Clearance of IND Application for BSI-082, a Novel Anti-SIRPα Monoclonal Antibody

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that the U.S. Food and Drug Administration. ....

Hughm Davis , Mingjiu Chen , Business Development , Biosion United States Inc , Prnewswire Biosion United States Inc , Drug Administration , Biosion Inc , United States , Investigational New Drug , Chief Executive Officer , Antibody Drug Conjugates , Chief Business , Development Officer , Biosion United States , Health Care Amp Hospitals , Clinical Trials Amp Medical Discoveries ,

Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC)

- First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2- Dosing of first ....

Hughm Davis , Wayne Saville , Heidi Wang , Biosion Syntracer , Adagloxad Simolenin , Biosion Inc , Pharma Inc , Business Development , Biosion United States Inc , Drug Administration , High Throughput Endocytosis Platform , Chief Business , Development Officer , Biosion United States , Chief Medical Officer , Chief Executive Officer , Thailand Business ,

OBI Pharma Inc.: OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Inc.: OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

T Ai Pei , Adagloxad Simolenin , Wayne Saville , Kevin Poulos , Heidi Wang , Pharma Inc , Drug Administration , Futures Bureau , Biosion Inc , Chief Medical Officer , Chief Executive Officer , Private Securities Litigation Reform Act , Taiwan Securities ,

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

T Ai Pei , Kevin Poulos , Wayne Saville , Heidi Wang , Adagloxad Simolenin , Biosion Inc , Pharma Inc , Drug Administration , Futures Bureau , Chief Medical Officer , Chief Executive Officer , Private Securities Litigation Reform Act , Taiwan Securities ,

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the evaluation. ....

Hughm Davis , Prnewswire Biosion United States Inc , Biosion Inc , United States , Development Officer , Biosion United ,